Alignment Healthcare Inc(ALHC) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | 43.81 | EPS (ttm) | 0.19 | Insider Own | 4.36% | Shs Outstand | 207.2M | Perf Week | -3.08% |
| Market Cap | 1.70B | Forward P/E | 25.72 | EPS next Y | 118.5% | Insider Trans | -20.41% | Shs Float | 198.4M | Perf Month | 3.41% |
| Enterprise Value | - | PEG | - | EPS next Q | -0.04 | Inst Own | 114.9% | Short Float | 12.86% | Perf Quarter | -56.05% |
| Income | 0.04B | P/S | 0.37 | EPS this Y | - | Inst Trans | 10.37% | Short Ratio | 3.09 | Perf Half Y | -62.34% |
| Sales | 4.58B | P/B | 6.39 | EPS next 5Y | - | ROA | 3.57% | Short Interest | 25.52M | Perf YTD | -58.58% |
| Book/sh | 1.28 | P/C | - | EPS past 3/5Y | 83.51% 50.33% | ROE | 20.04% | 52W High | -67.44% ($25.12) | Perf Year | -54.66% |
| Cash/sh | - | P/FCF | 9.56 | Sales past 3/5Y | 40.16% 32.71% | ROIC | 6.83% | 52W Low | 36.11% ($6.01) | Perf 3Y | 19.59% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 173.03% | Gross Margin | - | Volatility(W/M) | 4.14% 6.38% | Perf 5Y | -58.87% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | 37.21% | Oper. Margin | 1.2% | ATR (14) | 0.53 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | - | EPS Q/Q | 127.27% | Profit Margin | 0.89% | RSI (14) | 41.1 | Recom | 1.81 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.7 | Sales Q/Q | 31.55% | SMA20 | -0.47% ($8.22) | Beta | 1.05 | Target Price | $12.31 |
| Payout | - | Debt/Eq | 1.25 | Earnings | 2026/10/29 | SMA50 | -18.85% ($10.08) | Rel Volume | 0.56 | Prev Close | $8.05 |
| Employees | 1849 | LT Debt/Eq | 1.25 | EPS/Sales Surpr. | 31.78% 1.96% | SMA200 | -51.72% ($16.94) | Avg Volume(3M) | 8.25M | Price | $8.18 |
| IPO | 2021/3/26 | Option/Short | Yes/Yes | Trades | 22370 | Volume | 4,655,169 | Change | 1.61% |
A U.S. health insurance company that provides Medicare Advantage plans. It operates technology-driven Medicare Advantage insurance plans for seniors, offering exposure to subscriber growth and medical management. The company is a player in the technology-based Medicare Advantage space.
Over the past 1 year, on the lower side
67% below its 1-year high.
Traded less than usual. That is 56% of its average volume.
Next earnings report: October 29
That is today.
ALHC earns at a steady pace
Of every $100 in sales, $1.20 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +118.5% this year.
Tap to view numbers
The price is about the industry average
For a company expected to earn $100 next year, you would pay $2,572. Peers typically go for $1,749.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -58.9%. The S&P 500 did +69% over the same period.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership is about average
Institutions hold 114.9%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #11 of 11 in the industry
Based on market cap of $2B.
FAQ
What kind of company is ALHC?
ALHC belongs to the Healthcare sector and operates in the Healthcare Plans industry.
What is the market cap of ALHC?
The market cap of ALHC is approximately $1.7B, ranking 2,199 within its sector.
What is the P/E ratio of ALHC?
ALHC has a P/E ratio of approximately 43.8x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for ALHC?
ALHC has recorded a 52-week high of $25.12 and a low of $6.01.